HIM
WST icon

Hillsdale Investment Management’s West Pharmaceutical WST Stock Holding History

Hillsdale Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30
Closed -$12K – 621
2022
Q1 		$12K Hold
30
– – ﹤0.01% 523
2021
Q4 		$14K Hold
30
– – ﹤0.01% 537
2021
Q3 		$13K Hold
30
– – ﹤0.01% 526
2021
Q2 		$11K Sell
30
-1,780
-98% -$588K ﹤0.01% 538
2021
Q1 		$509K Sell
1,810
-50
-3% -$14.3K 0.04% 360
2020
Q4 		$526K Buy
1,860
+30
+2% +$8.42K 0.05% 340
2020
Q3 		$502K Buy
+1,830
New +$484K 0.05% 319
2019
Q4 		– Sell
-3,300
Closed -$468K – 671
2019
Q3 		$468K Buy
+3,300
New +$454K 0.04% 367
2018
Q1 		– Sell
-80
Closed -$8K – 539
2017
Q4 		$8K Sell
80
-12,000
-99% -$1.18M ﹤0.01% 373
2017
Q3 		$1.16M Hold
12,080
– – 0.2% 114
2017
Q2 		$1.14M Buy
12,080
+80
+0.7% +$7.36K 0.22% 85
2017
Q1 		$979K Hold
12,000
– – 0.19% 112
2016
Q4 		$1.02M Buy
12,000
+2,200
+22% +$173K 0.21% 112
2016
Q3 		$730K Buy
9,800
+3,500
+56% +$278K 0.19% 77
2016
Q2 		$478K Hold
6,300
– – 0.14% 101
2016
Q1 		$437K Buy
+6,300
New +$379K 0.15% 117
2014
Q4 		– Sell
-100
Closed -$4K – 598
2014
Q3 		$4K Hold
100
– – ﹤0.01% 532
2014
Q2 		$4K Hold
100
– – ﹤0.01% 532
2014
Q1 		$4K Hold
100
– – ﹤0.01% 525
2013
Q4 		$5K Sell
100
-100
-50% -$4.68K ﹤0.01% 517
2013
Q3 		$8K Buy
+200
New +$7.63K ﹤0.01% 477

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Hillsdale Investment Management's WST Position: Q2 2022 in Review

Hillsdale Investment Management sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 30 shares — an estimated $12K sold.

Hillsdale Investment Management first reported a position in WST in Q3 2013 and held it in 21 quarters. The position peaked at $1.16M in Q3 2017. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Hillsdale Investment Management reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 30 West Pharmaceutical shares in Q2 2022, an estimated $12K.
  • Hillsdale Investment Management first reported a position in West Pharmaceutical in Q3 2013 and held it in 21 quarters.
  • Hillsdale Investment Management's West Pharmaceutical position peaked at $1.16M in Q3 2017.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Hillsdale Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.